ClearPoint Neuro (CLPT) Shares Outstanding (2011 - 2026)

ClearPoint Neuro (CLPT) has 15 years of Shares Outstanding (Entity) data on file, last reported at $30.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Entity) rose 7.17% year-over-year to $30.0 million; the trailing twelve-month figure through Mar 2026 stood at $30.0 million (up 7.17% YoY), and the FY2025 full-year result was $29.4 million, up 6.34% from the prior year.
• Shares Outstanding (Entity) advanced to $30.0 million in Q1 2026, from $29.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $30.0 million in Q1 2026 to a low of $23.7 million in Q1 2022.
• A 5-year average of $26.5 million and a median of $27.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) rose 14.65% in 2022 and increased 0.3% in 2023, its largest moves.
• Tracing CLPT's Shares Outstanding (Entity) over 5 years: stood at $24.6 million in 2022, then grew by 0.3% to $24.7 million in 2023, then advanced by 12.03% to $27.6 million in 2024, then climbed by 6.34% to $29.4 million in 2025, then climbed by 2.1% to $30.0 million in 2026.
• Business Quant data shows CLPT's Shares Outstanding (Entity) at $30.0 million in Q1 2026, $29.4 million in Q4 2025, and $28.4 million in Q3 2025.